Dihydrolipoamide dehydrogenase suppression induce human tau phosphorylation by increasing whole body glucose levels in a<i>C</i>.<i>elegans</i>model of Alzheimer’s Disease
bioRxiv (Cold Spring Harbor Laboratory)